Morgan Xu
Directeur/Membre du Conseil chez Renova Therapeutics, Inc.
Postes actifs de Morgan Xu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Renova Therapeutics, Inc.
 Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Morgan Xu
Formation de Morgan Xu
| Harvard College | Undergraduate Degree |
| Harvard Business School | Doctorate Degree |
| Fudan University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Chine | 2 |
Opérationnelle
| Undergraduate Degree | 2 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | Health Technology |
